For sale: the Framingham Heart Study
Article Abstract:
Topics discussed concern the ethical questions surrounding the decision by Framingham Genomics Medicine to sell data from a long-term, government-funded heart study. Issues discussed concern medical ethics, conflicts of interest, and the potential exclusivity of biomedical research.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Will research be restricted by new data privacy rules ... and more oversight?
Article Abstract:
New rules guarantee patient control over how their medical records can be use, but may hamper medical research. The National Human Research Protection Advisory Committee will make recommendations about how research institutions practice medical ethics.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Race for pandemic flu vaccine rife with hurdles
Article Abstract:
The international health community needs a human vaccine for the bird flu pandemic that is sweeping a cluster of Asian countries. The race for a vaccine, which began in 1997, is faced with obstacles, but researchers are optimistic and feel that obstacles have been treated sensibly.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Rx for health & beauty: build up to the benefits of a moderate workout. More than beauty: a better body helps you inside and out
- Abstracts: Simply soy: easy, tasty ways to get more of this healthy protein. Foods of the Millennium: from feel-good fats to biotech backlash
- Abstracts: The new and improved 88th Annual Congress and Expo offers infinite solutions. Congress blows into the windy city
- Abstracts: Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
- Abstracts: A 25-year-old with asthma cardiac failure, diarrhea, and weakness of the right hand. A 69-year-old woman with pleuritic pain and a pulmonary arterial obstruction